King Pharmaceuticals KG Balance Sheet Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $24.63M+475% | $4.29M-22.8% | ||
| $9.35M— | $0— | ||
| $383.67M— | $0— | ||
| $1.01B+18,229% | $5.51M— | ||
| $174.4M— | $0— | ||
| $881.67M+97,430% | $904K— | ||
| 100K+270% | 27K— | ||
| $1.2M+122% | -$5.53M— | ||
| $128.28M+2,685% | $4.61M— | ||
| $1.01B+18,229% | $5.51M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are King Pharmaceuticals's total assets?
- King Pharmaceuticals (KG) holds $964.2M in total assets.
- How much debt does King Pharmaceuticals have?
- King Pharmaceuticals carries $176.7M in total debt against $121.4M of shareholders' equity, a debt-to-equity ratio of 1.46.
- How much cash does King Pharmaceuticals have?
- King Pharmaceuticals holds $62.2M in cash and equivalents.
- Where does King Pharmaceuticals's balance sheet data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
